Report #2858211

Received Sep 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: NH
Recovered: Unknown
Vaccinated: Aug 31, 2025
Onset: Aug 31, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	NC3C7	IM

Symptoms (1)

Expired product administered

Symptom narrative

Arexvy was administered 11 days past its expiration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 81-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number NC3C7, expiry date 20-AUG-2025) for prophylaxis. On 31-AUG-2025, the patient received Arexvy (intramuscular). On 31-AUG-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Arexvy was administered 11 days past its expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 2-Sep-2025 On 31-Aug-2025 a dose of Arexvy was administered to patient 11 days past its expiration date.